Clinical Trial Update: A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluated a combination of inhaled budesonide and ipratropium in patients at risk of developing ARDS. The study completed Phase 1 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Budesonide (BUDESONIDE)
• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

Sponsor: Damanhour University | Conditions: ARDS, Prevention and Control | Phase 1, Phase 2 | Status: COMPLETED